SQI Diagnostics Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SQIDF research report →
Price Chart
About the company
SQI Diagnostics Inc. operates as a precision medicine firm, engaged in the global identification, advancement, and marketing of swift diagnostic solutions tailored for medical professionals, patients, and the general public. Its diverse product portfolio features TOR-dx, a specialized lung test designed to help surgeons evaluate the condition of donor lungs.
- CEO
- Andrew Morris
- IPO
- 2009
- HQ
- Toronto, ON, CA
Get TickerSpark's AI analysis on SQIDF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $6.07M
- P/E
- -0.45
- PEG
- 0.01
- P/S
- 1.06
- P/B
- -0.84
- EV/EBITDA
- -2.35
- Div Yield
- 0.00%
- Gross Margin
- 38.30%
- Op Margin
- -241.42%
- Net Margin
- -228.62%
- ROE
- 447.09%
- ROIC
- -302.55%
Latest fiscal year · YoY change
- Revenue
- $8.10M+783.5%
- Gross Profit
- $3.10M+304.6%
- Op Income
- $-19,560,000
- Net Income
- $-18,523,000-75.5%
- EPS
- $-0.05-52.2%
- OCF Growth
- -13.5%
- FCF Growth
- -7.3%
- 52W High
- $0.01
- 52W Low
- $0.01
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- -0.36
- RSI (14)
- 36
- Avg Volume
- 0
No earnings-call transcripts are available for SQIDF yet.
- Free Float
- 25.9%
- Shares Outstanding
- 407.17M
- Float Shares
- 105.57M
Our SQIDF coverage
Recent articles, reports, and earnings notes.
No research on SQIDF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SQIDF report →SQI Diagnostics Appoints Andrew Morris as Chief Executive Officer, and Grants Options
prnewswire.com · Sep 13
SQI Diagnostics Inc. Announces Grant of Stock Options
prnewswire.com · Aug 30
SQI Diagnostics Reports Third Quarter 2021 Results
prnewswire.com · Aug 18
FDA Stops Emergency Use Authorization Review of SQI Diagnostics RALI-Dx™ IL-6 Severity Triage Test for COVID-19 Patients
prnewswire.com · Jul 23
SQI Diagnostics and AZOVA sign distribution agreement to sell SQI's COVID-19 HOME Antibody Test
prnewswire.com · Jul 15
SQI Diagnostics Inc. Announces $3.9 Million Funding via Warrant Exercise by Insiders
prnewswire.com · Jun 15
SQI Diagnostics Inc. Announces Grant of Stock Options
prnewswire.com · May 27
SQI Diagnostics Reports Second Quarter 2021 Results and Announces Departure of CEO and Appointment of Interim CEO
prnewswire.com · May 21
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.